The epithelial-to-mesenchymal transition (EMT), an embryonic program relaunched during wound healing and in pathological conditions such as fibrosis and cancer, continues to gain the attention of the research community, as testified by the exponential trend of publications since its discovery in the seventies. From the first description as a mesenchymal transformation, the concept of EMT has been substantially refined as an in-depth comprehension of its functional role has recently emerged thanks to the implementation of novel mouse models as well as the use of sophisticated mathematical modeling and bioinformatic analysis. Nevertheless, attempts to targeting EMT in fibrotic diseases are at their infancy and continue to pose several challenges. The aim of this mini review is to recapitulate the most recent concepts in the EMT field and to summarize the different strategies which have been exploited to target EMT in fibrotic disorders.
CITATION STYLE
Lovisa, S. (2021, September 7). Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2021.737570
Mendeley helps you to discover research relevant for your work.